TMIT-BODY Trademark

Trademark Overview

On Friday, October 22, 2021, a trademark application was filed for TMIT-BODY with the United States Patent and Trademark Office. The USPTO has given the TMIT-BODY trademark a serial number of 97087379. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, March 6, 2023. This trademark is owned by Crossbow Therapeutics, Inc.. The TMIT-BODY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, antivirals
tmit-body

General Information

Serial Number97087379
Word MarkTMIT-BODY
Filing DateFriday, October 22, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer and immunological diseases and disorders; Pharmaceutical preparations, namely, antivirals
Pseudo MarkTMIT BODY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, March 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCrossbow Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, March 6, 2023ABANDONMENT - AFTER PUBLICATION
Saturday, March 4, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Monday, October 3, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 1, 2022ASSIGNED TO EXAMINER
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 26, 2021NEW APPLICATION ENTERED

Related Keywords

body tmit preparations pharmaceutical diseases treatment disorders immunological cancer prevention viral infectious